Actively Recruiting
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy
Led by Mayo Clinic · Updated on 2026-03-30
25
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study evaluates changes in skin quality and self-esteem among breast cancer patients who are initiating aromatase inhibitor therapy.
CONDITIONS
Official Title
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female aged 18 years or older
- Postmenopausal women suitable to receive aromatase inhibitor therapy as per physician's discretion
- Histologically confirmed breast adenocarcinoma stage 0 to III that is estrogen receptor and/or progesterone receptor positive
- No prior chemotherapy or endocrine therapy for current breast cancer (prior use of tamoxifen, raloxifene, or prevention agents allowed)
- Willing to avoid facial procedures like facials, neurotoxin injections, fillers, or lasers during the study
- Able and willing to provide consent
You will not qualify if you...
- Prior use of aromatase inhibitors
- Use of prescription tretinoin, neurotoxin injections, fillers, facial lasers, microneedling, or facials within 6 months before study consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224-9980
Actively Recruiting
Research Team
C
Clinical Trials Referral Office
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here